U.S. Federal Funding for HIV/AIDS: Trends Over Time
This fact sheet provides an updated overview of federal funding for HIV/AIDS, highlighting key domestic and global HIV/AIDS programs and comparisons over time.
View the Latest: Financing
Filter
-
-
Global Health Funding in the FY 2024 Final Appropriations Bill
Fact SheetUpdated: March 25, 2024 On March 23, 2024, the President signed the second package of final FY 2024 appropriations bills, otherwise known as the “Further Consolidated Appropriations Act, 2024,” which was released by the House and Senate Appropriations Committees on March 20, 2024, passed by the House on March 22, 2024 and passed by the…
-
Gross Medicare Spending on Ozempic and Other GLP-1s Is Already Skyrocketing – Even Though Medicare Cannot Cover The Drugs for Weight Loss
News ReleaseA KFF analysis shows that gross total Medicare spending on Ozempic and other similar drugs has increased dramatically in recent years – even though Medicare is explicitly prohibited by law from covering the drugs for obesity. That’s because Medicare now covers the drugs, known as GLP-1s, for other medically accepted indications, including to treat diabetes.
-
Medicare Spending on Ozempic and Other GLP-1s Is Skyrocketing
Policy WatchThis policy watch analyzes the latest data on Medicare Part D spending on GLP-1 drugs, initially approved to treat diabetes but in high demand as treatments for obesity, and shows how spending on these drugs has increased substantially in recent years.
-
Domestic HIV Funding in the White House FY 2025 Budget Request
Issue BriefThis data note provides details on the FY25 request for domestic HIV programs and comparisons to the FY23 enacted level, where possible.
-
Global Health Funding in the FY 2025 President’s Budget Request
Fact SheetPresident Biden released his FY 2025 Budget Request on March 11, 2024. Since FY 2024 appropriations have not been finalized yet, comparisons here are made to the FY 2023 enacted level.
-
Halfway Through the Medicaid Unwinding, About 16 Million Enrollees Have Been Dropped
News ReleaseTen months into the unwinding of the Medicaid continuous enrollment provision, states have reported renewal outcomes for half of all enrollees whose eligibility needs to be reviewed during the unwinding period, including 34% (32.1 million) who have had their coverage renewed, and 17% (16.
-
Medicaid: What to Watch in 2024
Issue BriefAs the start of 2024, many issues are at play that will affect Medicaid coverage, financing, and access. This issue brief provides context for these Medicaid issues and highlights key issues to watch in the year ahead.
-
Medicaid and State Financing: What to Watch in Upcoming State Budget Debates
Issue BriefState legislatures are currently gathering to develop new budgets for state fiscal year (FY) 2025. Heading into this budget cycle, state fiscal conditions are shifting, with state revenues starting to decline following steep revenue growth during the pandemic. This issue brief examines trends in state fiscal conditions and discusses how state budgets and macroeconomic conditions may affect individuals and state Medicaid programs.
-
A Look at Medicaid Enrollment and Spending Trends and an Array of Policy Issues Amid Unwinding of the Continuous Enrollment Provision
Event Date:EventOn November 14, 2023 KFF and the National Association of Medicaid Directors (NAMD) held a web briefing to discuss the latest trends in Medicaid enrollment and spending and highlight key Medicaid policy changes that states implemented in state FY 2023 or plan to implement in FY 2024.